tiprankstipranks
Trending News
More News >
Recordati Industria Chimica e Farmaceutica SPA (RCDTF)
OTHER OTC:RCDTF

Recordati Industria Chimica e Farmaceutica SPA (RCDTF) Stock Statistics & Valuation Metrics

Compare
19 Followers

Total Valuation

Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of €12.29B. The enterprise value is $12.73B.
Market Cap€12.29B
Enterprise Value$12.73B

Share Statistics

Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding209,125,150
Owned by Insiders0.08%
Owned by Institutions

Financial Efficiency

Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee544.56K
Profits Per Employee96.86K
Employee Count4,300
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 0.00. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00

Income Statement

In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.34B and earned 416.50M in profits. Earnings per share was 0.00.
Revenue2.34B
Gross Profit1.64B
Operating Income638.90M
Pretax Income547.20M
Net Income416.50M
EBITDA857.80M
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was 569.90M and capital expenditures -50.18M, giving a free cash flow of 519.72M billion.
Operating Cash Flow569.90M
Free Cash Flow519.72M
Free Cash Flow per Share2.49

Dividends & Yields

Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of $1.389, resulting in a dividend yield of 2.34%
Dividend Per Share$1.389
Dividend Yield2.34%
Payout Ratio27.00%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.51
52-Week Price Change12.70%
50-Day Moving Average55.64
200-Day Moving Average55.83
Relative Strength Index (RSI)71.38
Average Volume (3m)69.00

Important Dates

Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 13, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend DateMay 19, 2025

Financial Position

Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 130.70M in taxes.
Income Tax130.70M
Effective Tax Rate0.24

Enterprise Valuation

Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Recordati Industria Chimica e Farmaceutica SPA has €235.02M in cash and marketable securities with €992.19M in debt, giving a net cash position of -€235.02M billion.
Cash & Marketable Securities€235.02M
Total Debt€992.19M
Net Cash-€235.02M
Net Cash Per Share-€1.12
Tangible Book Value Per Share€0.00

Margins

Gross margin is 69.94%, with operating margin of 27.28%, and net profit margin of 17.79%.
Gross Margin69.94%
Operating Margin27.28%
Pretax Margin23.37%
Net Profit Margin17.79%
EBITDA Margin36.63%
EBIT Margin28.89%

Analyst Forecast

The average price target for Recordati Industria Chimica e Farmaceutica SPA is €61.22, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€61.22
Price Target Upside2.58% Upside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis